Intravitreal bevacizumab stabilized vision in eyes with CNV and angioid streaks. At younger ages, CNV behaved more aggressively and seemed to be more resistant to treatment.

The findings of the present study show that the tamponade used in RRD surgery can affect the retinal layers differently. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:41-47.].

Purpose. To compare the efficacy of intravitreal triamcinolone (IVT) and intravitreal bevacizumab (IVB), both combined with grid laser photocoagulation (GLP) for macular edema (ME) secondary to branch retinal vein occlusion (BRVO). Methods. Retrospective, comparative study. The newly diagnosed patients with ME secondary to BRVO who were treated with IVT and GLP or IVB and GLP were included. The main outcome measures were changed in the best corrected visual acuity (BCVA) and central retinal thickness (CRT) from the baseline to month 24. Results. Ninety-nine eyes of 99 patients were included. The change in BCVA was not statistically different in any time points between the two groups (P > 0.05, for all). The change in CRT was not statistically different in any time points between the two groups (P > 0.05, for all). The mean number of injections at month 24 was 2.38 ± 1.06 in the IVT+GLP group and 4.17 ± 1.30 in the IVB+GLP group (P = 0.0001). The need for cataract surgery (P = 0.01) and secondary glaucoma (P = 0.03) occurrence were more common in IVT group. Conclusion. Both treatment modalities were effective in the treatment of ME secondary to BRVO. The number of injections was significantly lower in the IVT group than in the IVB group; however cataract and secondary glaucoma were more frequent in the IVT+GLP group than in the IVB+GLP group.

The aim of this study was to evaluate the parameters and outcomes of diode laser ablation therapy in retinopathy of prematurity. Materials and Methods: This retrospective study included infants who were treated with photocoagulation due to retinopathy of prematurity in Adana Numune Training and Research Hospital. Demographic characteristics of the patients, clinical findings, treatment parameters and outcomes were analyzed. Results: Diode laser photocoagulation was performed in 283 eyes of 142 babies with retinopathy of prematurity. 70 patients (49.3%) were female and 72 patients (50.7%) were male. The mean birth weight was 1316 ± 457 grams and the mean postmenstrual week was 29.4 ± 2.7. The mean postmenstrual week of treatment was 38 ± 3.2. The mean level of laser energy was found to be 167.8 ± 21.6 mW (100-280 mW) and the mean number of laser spots was 1728.1 ± 789.4 (100-5600). Due to the progression of the retinopathy, 24 eyes (8.5%) were received additional laser treatment. Vitreoretinal surgery was performed in a tertiary center after laser treatment in 8 advanced stage eyes (2.8%) who were referred to us from another hospital. In 275 patients (97.2%), diode laser treatment was performed effectively and anatomical success was achieved. Conclusion:Diode laser photocoagulation provides a high anatomical success in the treatment of retinopathy of prematurity. Close and careful follow up and early referral, where necessary is crucial for these patients.